• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Part B: Supplementary Information Sheet (SIS)
FR Recognition List Number 051 Date of Recognition 01/14/2019 
FR Recognition Number 10-93
Standard
ANSI Z80.27-2014
American National Standard for Ophthalmics - Implantable Glaucoma Devices
Scope/Abstract
The scope of this standard applies to devices that are implanted in the eye to treat glaucoma by facilitating aqueous outflow. The standard excludes glaucoma devices whose effect depends upon metabolic and/or pharmacologic mechanisms.
Extent of Recognition
Partial recognition. The following part(s) of the standard is (are) not recognized
Clause 7.4 Ethylene oxide sterilant residues
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.

This standard is recognized in part because:
Clause 7.4 (ethylene chlorohydrin limit) conflicts with an existing published final guidance. See guidance #2 below (MIGS).
Clause 7. 4 (ethylene oxide limit) conflicts with another recognized standard. See reference #4 below (ISO 11979-8).
Public Law, CFR Citation(s) and Procode(s)
Regulation Number Device Name Device Class Product Code
§886.3920 Implant, Eye Valve Class 2 KYF
Unclassified Intraocular Pressure Lowering Implant Class 3 OGO
Relevant FDA Guidance and/or Supportive Publications
1. Guidance for Industry and for FDA Reviewers/Staff: Aqueous Shunts - 510(k) Submissions, Issued November 16, 1998.

2. Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical (MIGS) Devices: Guidance for Industry and Food and Drug Administration Staff, Issued December 15, 2015.

3. Endotoxin Testing Recommendations for Single-Use Intraocular Ophthalmic Devices: Guidance for Industry and Food and Drug Administration Staff, Issued August 17, 2015.

4. ISO 11979-8 Ophthalmic implants - Intraocular lenses - Part 8: Fundamental requirements.

FDA Technical Contact
 Claudine Krawczyk
  FDA/OMPT/CDRH/ODE/DOED/ICIB/
  301-796-6860
  claudine.krawczyk@fda.hhs.gov
Standards Development Organization
ANSI American National Standards Institute https://www.ansi.org/
FDA Specialty Task Group (STG)
Ophthalmic
-
-